Related references
Note: Only part of the references are listed.Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
Silvia Cerboni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Direct-acting antivirals: the endgame for hepatitis C?
Roberta D'Ambrosio et al.
CURRENT OPINION IN VIROLOGY (2017)
Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway
Suruchi N. Schock et al.
CELL DEATH AND DIFFERENTIATION (2017)
An innate antiviral pathway acting before interferons at epithelial surfaces
Marie B. Iversen et al.
NATURE IMMUNOLOGY (2016)
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature
David Kavanagh et al.
BLOOD (2016)
Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine-Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING)
Thierry Lioux et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS
Line S. Reinert et al.
NATURE COMMUNICATIONS (2016)
Discriminating self from non-self in nucleic acid sensing
Martin Schlee et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Understanding natural herpes simplex virus immunity to inform next-generation vaccine design
Kerrie J. Sandgren et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Activation and Regulation of DNA-Driven Immune Responses
Soren R. Paludan
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2015)
Antiviral drug discovery: broad-spectrum drugs from nature
J. P. Martinez et al.
NATURAL PRODUCT REPORTS (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Viruses transfer the antiviral second messenger cGAMP between cells
A. Bridgeman et al.
SCIENCE (2015)
Transmission of innate immune signaling by packaging of cGAMP in viral particles
Matteo Gentili et al.
SCIENCE (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Activation of the STING Adaptor Attenuates Experimental Autoimmune Encephalitis
Henrique Lemos et al.
JOURNAL OF IMMUNOLOGY (2014)
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
John W. Schoggins et al.
NATURE (2014)
Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Lingyin Li et al.
NATURE CHEMICAL BIOLOGY (2014)
Activated STING in a Vascular and Pulmonary Syndrome
Y. Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Binding-Pocket and Lid-Region Substitutions Render Human STING Sensitive to the Species-Specific Drug DMXAA
Pu Gao et al.
CELL REPORTS (2014)
Structure-Function Analysis of STING Activation by c[G(2′,5′) pA(3′,5′)p] and Targeting by Antiviral DMXAA
Pu Gao et al.
CELL (2013)
Cyclic [G(2′,5′) pA(3′,5′)p] Is the Metazoan Second Messenger Produced by DNA-Activated Cyclic GMP-AMP Synthase
Pu Gao et al.
CELL (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
Andrea Ablasser et al.
NATURE (2013)
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
Jiaxi Wu et al.
SCIENCE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
Xiao-Dong Li et al.
SCIENCE (2013)
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
Kalyan Das et al.
CURRENT OPINION IN VIROLOGY (2013)
Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis
Nicolas Boivin et al.
ANTIVIRAL RESEARCH (2012)
Mycobacterium Tuberculosis Activates the DNA-Dependent Cytosolic Surveillance Pathway within Macrophages
Paolo S. Manzanillo et al.
CELL HOST & MICROBE (2012)
Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities
Peter M. Gray et al.
CELLULAR IMMUNOLOGY (2012)
From crucial to negligible: Functional CD8+ T-cell responses and their dependence on CD4+ T-cell help
Melanie Wiesel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice
Line S. Reinert et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Revealing the role of CD4+ T cells in viral immunity
Andrea J. Sant et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Imiquimod Suppresses Propagation of Herpes Simplex Virus 1 by Upregulation of Cystatin A via the Adenosine Receptor A1 Pathway
Yuji Kan et al.
JOURNAL OF VIROLOGY (2012)
Modulating immunity as a therapy for bacterial infections
Robert E. W. Hancock et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
Jocelyne Piret et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Long-term remission of recurrent herpes labialis following topical imiquimod application on distant healthy skin: a clinical and immunological study
Dionysios Tsambaos et al.
ANTIVIRAL THERAPY (2011)
Innate Immune Recognition of an AT-Rich Stem-Loop DNA Motif in the Plasmodium falciparum Genome
Shruti Sharma et al.
IMMUNITY (2011)
Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review
Nicky Perkins et al.
SEXUALLY TRANSMITTED INFECTIONS (2011)
Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
Thomas Ebensen et al.
VACCINE (2011)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Coding of facial expressions of pain in the laboratory mouse
Dale J. Langford et al.
NATURE METHODS (2010)
c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response
Joshua J. Woodward et al.
SCIENCE (2010)
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
Sarah M. McWhirter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Katharine J. Looker et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
The antiviral activity of toll-like receptor 7 and 7/8 agonists
Richard L. Miller et al.
DRUG NEWS & PERSPECTIVES (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Michel Gilliet et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant
Thomas Ebensen et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Role of IFN-α/β signaling in the prevention of genital herpes virus type 2 infection
Alexandra Svensson et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2007)
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties
Thomas Ebensen et al.
VACCINE (2007)
Cutting edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ
Jennifer M. Lund et al.
JOURNAL OF IMMUNOLOGY (2006)
The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion
Michael P. Schoen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848)
MJ McCluskie et al.
ANTIVIRAL RESEARCH (2006)
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
EE Freeman et al.
AIDS (2006)
Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: A pilot study
DI Bernstein et al.
CLINICAL INFECTIOUS DISEASES (2005)
Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA
AA Ashkar et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2
AA Ashkar et al.
JOURNAL OF VIROLOGY (2003)
Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study
TW Schacker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis
A Wald et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Natural interferon α/β-producing cells link innate and adaptive immunity
N Kadowaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
